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Abstract
Background: Konjac glucomannan polysaccharide (KGM), inulin oligosaccharide (inulin) and their mixture has been
shown to modulate the gut-associated lymphoid tissue immunity.
Aims: The present study was mainly to determine effects of a low-level (2% w/w) KGM and inulin and their combination on dextran sodium sulfate (DSS)-induced colitis. We also determine the potential mechanisms mediating these
effects of dietary ﬁbers.
Methods: C57BL/6J mice (6 weeks of age, eight per group) were randomly assigned to consume one of the following
diets: control (DSS group) or control diet supplemented with 2% (w/w) of KGM (KGM group), 2% (w/w) of inulin
oligosaccharide (inulin group) or KGMþInulin (1%, w/w each (KþI group)) for 29 days, combined with the DSS
drinking water (2% w/v) treatment on days 21-26. Another group served as vehicle was fed the control diet and given
regular drinking water throughout the study. Fresh feces were collected on days 26-29. Mice were killed on day 30 after
fasting. Segments of distal colon were processed for histological procedure. The remaining colonic tissues were processed to determine the colonic gene expressions of cytokines, tight junction proteins and antioxidant enzymes.
Results: The present study indicated that DSS resulted in colonic dysplasia, severe leukocyte inﬁltration and enhanced
gene expressions of pro-inﬂammatory cytokines. All ﬁber treatments ameliorated these indices of colitis. DSS treatment
reduced the colonic gene expressions of tight junction proteins and antioxidant enzymes, which were ameliorated or
normalized with ﬁber supplementation. In addition, all ﬁber treatments prevented the DSS-induced alterations in the
fecal microbiota and short-chain acid levels.
Conclusion: Supplementation of low-level, 2% (w/w), of KGM polysaccharide, inulin oligosaccharide and K þ I reduced
the DSS-induced colitis and mucosal barrier dysfunction, which was likely to be mediated by the prebiotic effects.
Keywords: Colitis, Dextran sulfate sodium, Konjac glucomannan, Inulin, Microbiota, Mucosal barrier

Introduction

T

he ulcerative colitis is an inﬂammatory
bowel disease (IBD) that occurs in the colon
[1]. Epidemiological studies found that the

incidence and prevalence of IBD were the highest
in western countries [2]. The reported annual
incidence of ulcerative colitis was 24.3 and 19.2
per 100,000 person-years in Europe and North
America, respectively [2]. The incidence is still
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arising in low-incidence areas such as Asia and
developing countries [2]. The pathogenesis of IBD
is multifactorial, involving mucosal barrier defects, dysregulated immune responses, genetic
predisposition and environmental factors [3].
The mucosal barrier consists of mucosal layer, tight
junction and microﬂora, which protects the body
from potential pathogens [4]. The tight junctions form
the continuous intercellular barrier between the intestinal epithelial cells is required to separate tissue
spaces, regulate selective movement of solutes across
the epithelium and maintain the mucosal barrier
function [4]. The reduced expression of tight junction
protein may lead to translocation of endotoxins and
bacterial antigens and causes excessive inﬂammation
in the gut-associated lymphocyte tissue [4].
The colonic mucosa is constantly challenged by
the reactive oxidative substances produced from the
microbiota and lumen contents [5]. An imbalanced
cellular redox system of mucosa results excess
reactive oxidative substance levels and subsequently causes gastrointestinal tract inﬂammation
[5,6]. In addition, activated leukocytes during the
active phase of inﬂammation generate reactive
oxidative reactions that further impairs the mucosal
barrier [7]. Therefore, oxidative stress is considered
to play an important role in the mucosal damage in
IBD [5]. For examples, previous studies indicated
increased peroxidative products in both the ulcerative colitis mouse model and IBD patients [8,9].
Current medical treatments for IBD include corticosteroids, antibiotics, 5-aminosalicylic acid, immunomodulator and biological therapies [10].
Traditional therapy may cause side effects due to
immune-suppression [11]. Therefore, the need for
complementary and alternative medicine approaches
for prevention and treatment of IBD is increasing [12].
Konjac glucomannan (KGM) is a viscous soluble
ﬁber isolated from the underground tuber of
Amorphophallus konjac [13]. It is composed of b-1, 4linked D-glucose and D-mannose units joined
together with branches through b-1,6-glucosyl units
[13]. The KGM has been processed into various
vegetarian food products commonly consumed in
the Asian countries. Inulin, found in the underground tuber of chicory (Cichorium intybus), is an
oligomer or polymer of b-D-fructose containing two
to mostly sixty monomeric units that are linked by
b-(2 / 1) glycosidic bridges [14]. The fraction of
inulin with the degree of polymerization lower than
10, namely, inulin oligosaccharide, is widely used as
a supplement in functional food [15]. Both KGM and
inulin oligosaccharide have been shown to exert
healthy bowel effects, such as to increase the colonic
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microbial fermentation products short-chain fatty
acids and stimulate the growth of biﬁdobacteria and
lactobacilli in animal/human studies [14,16-18].
KGM and inulin modulate the colonic antioxidant
system and increased the antioxidant defense
against the oxidative stress resulted from a low-ﬁber
high-fat diet or a genotoxic carcinogen [18-20]. In
addition, a previous study indicated that either
KGM or inulin oligosaccharide could effectively
strengthen the colonic mucosal barrier and increase
the expressions of tight junction proteins occludin (a
transmembrane barrier protein) and zone occludin1 (ZO-1) (a peripheral scaffolding protein) [18].
These ﬁbers also modulate gut immunity by
increasing the colonic gene expression of IL-10, an
anti-inﬂammatory cytokine [16]. However, effects of
KGM and the combination of KGM and inulin
oligosaccharide on prevention of ulcerative colitis
have never been examined.
Dextran sodium sulfate (DSS) causes colonic intestinal epithelial cell injury and has been used to
induce experimental colitis [21,22]. The present
study was undertaken to investigate effects of KGM,
inulin oligosaccharide and their mixture on the
colonic inﬂammation, tight junction proteins, antioxidative enzymes, fecal microbiota and short-chain
fatty acids in a DSS-induced colitis mouse model. In
order to be applicable to humans, the level of ﬁber
supplementation was only 2% w/w, which is
equivalent to 10 g/d of normal human diet.

Methods
Animals
Male C57BL/6J mice were purchased at 5 weeks of
age from the National Laboratory Animal Breeding
and Research Center (Taipei, Taiwan). Animals
were housed in a solid-bottomed plastic cage with
stainless wire bar lid and wood shavings for
bedding in an animal holding room maintained on a
12-h light/dark cycle at 24 ± 1 C and 50 ± 2% humidity. All animals were allowed free access to
water and food in the present study. The care and
use of animals was in accordance with European
Commission Directive 86/609/EEC for animal
experiment [23] and the guidelines of the National
Research Council [24]. All experimental procedures
involving animals were approved by the Institutional Animal Care and Use Committee.
Experimental design
Mice (6 weeks of age, n ¼ 8 per group) were
randomly assigned into one of the following groups:
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vehicle, DSS, KGM, inulin and KþI. The vehicle
group consumed the control diet and regular
drinking water. The other mice were DSS-treated
groups; they were fed one of following diets: control
(DSS group) or ﬁber-supplemented diet (2% w/w
KGM (KGM group), 2% w/w inulin oligosaccharide
(inulin group), 1% w/w KGMþ1% w/w inulin
oligosaccharide (KþI group)) for 29 days and were
given 2% (w/v) DSS (molecular weight 36,00050,000, MP Biomedicals, Santa Ana, CA, USA) in
drinking water on days 21-26. The control diet was
modiﬁed from AIN-93G [25]. Compositions of all
experimental diets are shown in Table 1. The ﬁbersupplemented diets were adjusted based on the
purity of konjac and inulin powder to provide 2%
(w/w) dietary ﬁber supplementation. On days 26-29,
mice were individually housed for collection of fresh
feces. Mice were anaesthetized with CO2 and killed
on day 30 after an 18-h fasting. Segments (0.4 cm2) of
the distal colon were immediately ﬁxed in 10% (v/v)
buffered formalin for histological procedure. The
remaining tissues were frozen for further analysis.
Histological evaluation of distal colon
Tissue sections (4 mm) were stained with hematoxylin and eosin. The histology of colonic mucosal
layer was observed under a 200  magniﬁcation.
Determination of gene expression
The colonic gene expressions of cytokines (TNF-a,
IL-6 and IL-10), tight junction proteins (ZO-1
and occludin) and antioxidant enzymes including
glutathione peroxidase 2 (Gpx2), glutathione Stransferase p (Gstp1), catalase and superoxide dismutase (SOD) were determined using TaqMan
gene expression assays (Applied Biosystems Life
Table 1. Composition of experimental diets.
Group

Control1
(g/kg)

KGM
(g/kg)

Inulin
(g/kg)

KþI
(g/kg)

Maize starch
Casein
Sucrose
Soybean oil
Cellulose
Inulin oligosaccharide
Konjac glucomannan
AIN 93G Mineral Mix
AIN 93 Vitamin Mix
L-cystine
Choline bitartrate

529.5
200.0
100.0
70.0
50.0
35.0
10.0
3.0
2.5

504.5
200.0
100.0
70.0
50.0
25.0
35.0
10.0
3.0
2.5

506.1
200.0
100.0
70.0
50.0
23.4
35.0
10.0
3.0
2.5

505.3
200.0
100.0
70.0
50.0
11.7
12.5
35.0
10.0
3.0
2.5

KGM, Konjac glucomannan; KþI, Konjac glucomannan þ inulin
oligosaccharide; AIN, American institute of Nutrition.
1
The control diet was modiﬁed from AIN-93 G diet [25].
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Technologies, Foster City, CA, USA) by the method
described previously [18]. The TaqMan primer
identiﬁcation numbers of genes were provided in
the supplementary material. The quantitative realtime polymerase chain reaction was performed at
50 C for 2 min, 95 C for 10 min, and ﬁfty cycles at
95 C for 15 s and 60 C for 1 min. The relative gene
expression of each target gene was ﬁrst normalized
to that of glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and further calculated relative to the
level of the vehicle group using the comparative
threshold cycle (Ct) method. The fold difference in
gene expression was calculated as 2DDCt [26].
Determination of fecal short-chain fatty acids
Fecal acetate, propionate and n-butyrate were
extracted using ether by the method described
previously [18]. The fecal samples were injected
onto a gas chromatography (GC-2014, Shimadzu,
Tokyo, Japan) ﬁtted with a glass capillary column
(0.25 mm, 30 m Stabilwax-DA, Restek Corp., Bellefonte, PA, USA) and a ﬂame ionization detector by
the method described previously [18].
Quantiﬁcation of fecal bacteria
Fecal biﬁdobacteria, lactobacilli and Clostridia
were quantiﬁed by the ﬂuorescent in situ hybridization method as described previously [18, 27-28]. A
nucleic acid stain, 40 , 6-diamidino-2-phenylindole
was used to quantify the total fecal bacteria. The
microbial counts are expressed as log10 counts/g
feces.
Statistical Analyses
Data were presented as means and standard error
of means (S.E.M.) and analyzed using SPSS version
12. The body weights were analyzed using two-way
ANOVA with day and treatment factors. One-way
ANOVA followed by post hoc Tukey's honestly signiﬁcant difference test was used to determine variables across groups. Statistically signiﬁcant was
deﬁned as P < 0.05.

Results
The body weights from the initial day of the DSS
treatment (day 21) to the end of the study is shown
in Fig. 1. Two-way ANOVA indicated signiﬁcant
effect of day (P < 0.001) and interaction between day
and treatment (P ¼ 0.045). Further post-hoc statistical analysis across groups indicated that the body
weight of the DSS group was lower than the
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Figure 1. Body weight of vehicle and DSS-treated experimental mice
during days 21-29. Mean values with different superscript letter indicated signiﬁcantly different across groups (P < 0.05).

respective level of the vehicle group on day 27
(P ¼ 0.004), day 28 (P ¼ 0.001) and day 29 (P < 0.001),
respectively. The body weight of inulin group was
greater (P ¼ 0.004 vs DSS) than the level of DSS
group on day 29. KGM and KþI did not signiﬁcantly
affect the body weight compared with the respective
level of DSS group during days 21-29.
The cross-section histology of distal colon indicated severe dysplasia in the DSS group, which was
not observed in the vehicle and ﬁber-supplemented
groups (Fig. 2). In addition, the present study found
severe leukocyte inﬁltration throughout the lamina
propria and extending into the submucosal tissues
in the DSS group, which was not observed in the
vehicle and was ameliorated in ﬁber-supplemented
groups.
The DSS treatment signiﬁcantly up-regulated the
colonic gene expression of TNF-a (P < 0.001 vs
vehicle) and IL-6 (P < 0.001 vs vehicle), respectively
(Fig. 3). The gene expression of TNF-a in the KGM,
inulin or KþI was signiﬁcantly lower than that in the
DSS group (P < 0.001 for each ﬁber vs DSS,
respectively). Similarly, the gene expressions of IL-6
in all ﬁber-supplemented groups were signiﬁcantly
lower than that in the DSS group (P < 0.001 for each
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ﬁber vs DSS, respectively). On the other hand, DSS
treatment signiﬁcantly reduced the colonic gene
expression of IL-10 (P < 0.001 vs vehicle). The gene
expression of IL-10 in the KGM, inulin and KþI
group was signiﬁcantly greater than the level in the
DSS group, respectively (P < 0.001 for each ﬁber vs
DSS, respectively).
The DSS treatment signiﬁcantly down-regulated
the gene expressions of tight junction proteins ZO-1
(P < 0.001 vs vehicle) and occludin (P < 0.001 vs
vehicle) (Fig. 4). Supplementation of KGM, inulin
and KþI up-regulated the ZO-1 gene expression,
respectively (P < 0.001 for each ﬁber vs DSS,
respectively). All ﬁber supplementations also
enhanced the occludin gene expressions (P < 0.001
for each ﬁber vs DSS, respectively).
The DSS treatment signiﬁcantly down-regulated
the colonic gene expression of glutathione peroxidase (P < 0.001 vs vehicle), glutathione S-transferase
(P < 0.001 vs vehicle), catalase (P < 0.001 vs vehicle)
and SOD (P < 0.001 vs vehicle), respectively (Fig. 5).

Figure 3. Gene expressions of cytokines in the distal colon of vehicle and
DSS- induced mice. Relative gene expression was normalized using internal housekeeping gene GAPDH and compared to that of the vehicle
group according to the 2DDCt method. Bars are presented as mean and
standard error of means (n 8 per group). Mean values with unlike letters
are signiﬁcantly different across groups as analyzed by one-way ANOVA
followed by Tukey's honestly signiﬁcant difference test (P < 0.05).

Figure 2. Histology of the distal colon of vehicle and DSS- induced mice. Histology of the distal colon was observed under a 200 magniﬁcation. Scale
represents 50 mm.
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Figure 4. Gene expressions of tight junction proteins in the distal colon
of vehicle and DSS- induced mice. Relative gene expression was
normalized using internal control gene glyceraldehyde 3-phosphate
dehydrogenase (GAPDH) and compared with that of the vehicle group
according to the 2DDCt method. Bars are presented as mean and
standard error of means (n 8 per group). Mean values with unlike letters
are signiﬁcantly different across groups as analyzed by one-way
ANOVA followed by Tukey's honestly signiﬁcant difference test
(P < 0.05).

KGM, inulin and KþI ameliorated the DSS-induced
suppression of glutathione peroxidase gene
expression (P < 0.001 vs DSS, respectively) and
catalase gene expression (P < 0.001 vs DSS, respectively). The gene expressions of glutathione Stransferase in all ﬁber groups were normalized to
the level in the vehicle group (P > 0.05 for each ﬁber
vs vehicle, respectively), respectively. The gene expressions of SOD in all ﬁber groups were also
similar to that in the vehicle group (P > 0.05 for each
ﬁber vs vehicle, respectively).
The DSS treatment decreased the fecal lactobacilli
(P < 0.001 vs vehicle) and biﬁdobacteria (P < 0.001 vs
vehicle) concentrations (log10 counts/g feces) and
increased the Clostridia concentration (P < 0.001 vs
vehicle) compared with the respective level in the
vehicle group (Fig. 6). The fecal microbiota was
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normalized with all ﬁber treatments. However, the
fecal total bacterial concentration was not affected
with the DSS treatment and was similar across
groups.
The DSS treatment decreased the fecal acetate,
propionate, butyrate and total short-chain fatty acid
concentrations compared with the respective level
in the vehicle group (P < 0.001 vs vehicle, respectively) (Table 2). KGM, inulin and KþI increased the
fecal acetate by approximately 66.0% (P ¼ 0.012 vs
DSS), 47.0% (P ¼ 0.035 vs DSS) and 59.1% (P ¼ 0.028
vs DSS), respectively, compared with the level in the
DSS group. KGM, inulin and KþI increased the
fecal propionate by approximately by 54.2%
(P ¼ 0.030 vs DSS), 75.0% (P < 0.001 vs DSS) and
64.6% (P ¼ 0.010 vs DSS), respectively, compared
with the level in the DSS group. KGM, inulin and
KþI increased the fecal butyrate approximately by
1.3-fold (P < 0.001 vs DSS), 2.3-fold (P < 0.001 vs
DSS) and 2-fold (P < 0.001 vs DSS), respectively,
compared with the level in the DSS group. KGM,
inulin and KþI increased the fecal total short-chain
fatty acid by approximately 66.8% (P ¼ 0.015 vs
DSS), 57.9% (P ¼ 0.035 vs DSS) and 65.5% (P ¼ 0.018
vs DSS), respectively, compared with the level in the
DSS group.

Discussion
There are several unique aspects in the present
study. Firstly, the DSS administered in the present
study, 2% w/v, was lower than those used in previous studies, 3-8% w/v in drinking water [29-32].
The DSS-treated period in the present study was
also shorter than that shown in previous studies
[30,32]. Secondly, the present study determined the
preventive effects of dietary ﬁber on colitis, instead

Figure 5. Gene expressions of glutathione peroxidase (Gpx2), glutathione S-transferase p (Gstp1), catalase and superoxide dismutase (SOD) in the
distal colon of vehicle and DSS-induced mice. Relative gene expression was normalized using internal control gene glyceraldehyde 3-phosphate
dehydrogenase (GAPDH) and compared to that of the vehicle group according to the 2DDCt method. Bars are presented as mean and standard error of
means (n 8 per group). Mean values with unlike letters are signiﬁcantly different across groups as analyzed by one-way ANOVA followed by Tukey's
honestly signiﬁcant difference test (P < 0.05).
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Figure 6. Fecal bacterial concentrations (log10 counts/g feces). Bars are presented as mean and standard error of means (n 8 per group). Mean values
with unlike letters are signiﬁcantly different across groups as analyzed by one-way ANOVA followed by Tukey's honestly signiﬁcant difference test
(P < 0.05). The fecal total bacterial concentrations were not signiﬁcantly different across groups.

Table 2. Fecal short-chain fatty acid concentrations of vehicle and DSS-induced mice.1
Vehicle

DSS

KGM

Inulin

KþI

30.6 ± 0.6a
4.8 ± 0.1a
1.4 ± 0.1a
36.8 ± 0.8a

50.8 ± 0.8b
7.4 ± 0.4b
3.2 ± 0.1b
61.4 ± 1.3b

45.0 ± 0.7b
8.4 ± 0.3b
4.6 ± 0.1c
58.1 ± 1.2b

48.7 ± 1.0b
7.9 ± 0.3b
4.2 ± 0.1c
60.9 ± 1.4b

mmol/g feces
Acetate
Propionate
Butyrate
Total

65.3 ± 0.8c
10.3 ± 0.2c
3.3 ± 0.2b
78.9 ± 1.3c

KGM, Konjac glucomannan; KþI, Konjac glucomannan þ inulin oligosaccharide.
1
Data were expressed as mean values and standard error of means (n 8 per group). The differences across groups were determined
using one-way ANOVA followed by post hoc Tukey's honestly signiﬁcant difference test. Mean values with unlike letters are signiﬁcantly
different across groups as analyzed by one-way ANOVA followed by Tukey's honestly signiﬁcant difference test (P < 0.05).

of being an adjunct treatment during the active
phase of colitis [29-32]. Thirdly, the present study
compared effects of combination of polysaccharide
(KGM) and inulin oligosaccharide with single ﬁber
source on DSS-induced colitis. We further examined the potential underlying mechanisms that
mediated the anti-colitis effects of these dietary
ﬁbers.
In order to set up an optimally low DSS dose for
inducing experimental colitis, we examined the
outcomes of 2% (w/v) DSS water for 5 days in a pilot
study. With this low-dose DSS treatment, we
observed severe crypt destruction and leukocyte
inﬁltration in the distal colon, in agreement with the
those observed by other studies using higher dose
of DSS [29,30]. The present study further indicated
that this low-dose DSS treatment caused large increases in the colonic expression of pro-inﬂammatory cytokines TNF-a and IL-6, in agreement with
those observed in previous studies using higher
dose of DSS [29-31]. Therefore, the present study
suggested that 2% (w/v) DSS water for 5 days was
sufﬁcient to induce indices of colonic colitis such as
decreased body weight, severe crypt destruction
and inﬂammation in C57BL/6J mice. The colitis was
not conﬁrmed by the usual standards, such as the

disease activity index, colon length, and occult/
obvious fecal blood in the present study.
Fructo-oligosaccharide and inulin administrations
during the active colitis phase induced by DSS have
been shown to reduce the colonic mucosal lesion
[32-33]. In addition, fructo-oligosaccharide has been
shown to exert intestinal anti-inﬂammatory effect in
CD4þCD62LþT cell transfer model of colitis in mice
[34]. Our present results indicated that inulin
oligosaccharide effectively ameliorate DSS-induced
colitis, as evidenced by a normal mucosal lining, a
lesser body weight loss, lower expressions of proinﬂammatory cytokines and a higher expression of
IL-10 compared with the respective level in the DSS
group. Although KGM and KþI did not effectively
ameliorate the body weight loss, they prevented
mucosal lining damage and effectively modulated
colonic immunity. Therefore, the present study
suggested that these soluble ﬁbers could ameliorate
the pathogenesis of DSS-induced colitis.
The mucosal barrier contains microbiota that
could modulate the innate and adaptive immunity
of gut-associated lymphoid tissue [35,36]. Beneﬁcial
bacteria such as Biﬁdobacteria spp. and Lactobacillus
spp. is associated with a healthy intestinal homeostasis [37]. In response to these beneﬁcial bacteria,
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dendritic cells within the lamina propria release
TGF-b which activates T regulatory cells to release
IL-10 and TGF-b, leading to a more tolerant immune
phenotype [37]. The gut microbiota of IBD patients
is characterized by a reduced abundance of Biﬁdobacteria spp. and Lactobacillus spp. and a higher
abundance of Clostridium difﬁcile [37]. In agreement
with that, the present study observed higher fecal
Clostridia and lower lactobacilli and biﬁdobacteria
levels in the DSS group. Several studies have suggested beneﬁcial effects of probiotics, such as VSL#3
(mixture of several probiotics) and a single strain of
Biﬁdobacterium spp. on DSS-induced colitis [31,38].
Administration of VSL#3 during the DSS treatment
reduced severity of colitis and pro-inﬂammatory
cytokine levels [31]. Administration of Biﬁdobacterium spp. before and during the DSS treatment
ameliorated the severity of colitis and reduced the
colonic pro-inﬂammatory cytokine IL-1b [38]. The
present results indicated that all ﬁber treatments
prevented the DSS-induced alteration in the fecal
microbiota. Therefore, the anti-colitis effects of soluble ﬁber treatments in the present study may be
mediated by their prebiotic roles [39].
Inﬂammatory bowel disease is likely to be triggered by a leaky mucosal layer [4]. In this study, the
DSS treatment down-regulated the gene expressions of tight junction proteins, which suggested
that DSS might damage the mucosal barrier function. Soluble ﬁbers have been shown to up-regulate
the ZO-1 and occludin expressions in the wild-type
[18] and the occludin in the CD4þCD62LþT cell
transfer model of colitis mice [34]. In accordance
with previous studies, the present results indicated
that KGM and inulin oligosaccharide could beneﬁcially prevent the DSS-induced down-regulation of
ZO-1 and occludin expression, which possibly
contribute to their anti-colitis effects.
Previous in vitro studies have suggested that the
butyrate is vital for normal colonocyte proliferation
and increases the transcription of tight junction
proteins and induces ZO-1 and occludin redistributions in the cellular membrane [40-41]. In
the present study, all ﬁber treatments signiﬁcantly
enhanced the fecal butyrate level. Therefore, we
suggested that the butyrate derived from the dietary ﬁbers might prevent the DSS-induced
colonic mucosal dysplasia and the mucosal layer
damage.
The present study indicated reduced expressions
of colonic antioxidant enzymes in the DSS group,
which suggested an impaired colonic antioxidant
defense system in this colitis model. We have previously reported that 2% (w/w) KGM, inulin oligosaccharide and KþI up-regulated the expressions of
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colonic antioxidant enzymes [18]. The present study
further indicated that these dietary ﬁbers did not
just ameliorate the DSS-induced down-regulation in
colonic antioxidant enzymes, but also almost
normalized the expressions of glutathione S-transferase and SOD to the level of the vehicle group.
Therefore, the present study suggested that KGM,
inulin oligosaccharide and KþI pretreatment
strengthened the colonic antioxidant defense system
against the challenge caused by DSS.
In conclusion, the present study suggests that a
low-level, 2% (w/w), of KGM polysaccharide, inulin
oligosaccharide and the ﬁber mixture may prevent
the DSS-induced colitis, which is likely to be associated with the prebiotic role of these ﬁbers.
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